$164 Million is the total value of MPM BioImpact LLC's 10 reported holdings in Q1 2020. The portfolio turnover from Q4 2019 to Q1 2020 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| HARP | Harpoon Therapeutics, Inc. | $45,144,000 | -21.7% | 3,898,422 | 0.0% | 27.58% | +35.0% | |
| EPZM | Epizyme, Inc. | $36,162,000 | -37.0% | 2,331,534 | 0.0% | 22.09% | +8.7% | |
| TCRR | TCR2 Therapeutics, Inc. | $26,091,000 | -45.8% | 3,370,982 | 0.0% | 15.94% | -6.6% | |
| GTHX | G1 Therapeutics, Inc. | $15,690,000 | -58.3% | 1,423,794 | 0.0% | 9.58% | -28.1% | |
| MEI Pharma, Inc. | $10,063,000 | -35.1% | 6,250,000 | 0.0% | 6.15% | +11.9% | ||
| YMAB | YmAbs Therapeutics, Inc. | $8,803,000 | -16.5% | 337,291 | 0.0% | 5.38% | +44.0% | |
| CTMX | CytomX Therapeutics, Inc. | $6,561,000 | -7.7% | 855,437 | 0.0% | 4.01% | +59.1% | |
| SNSS | Sunesis Pharmaceuticals, Inc. | $1,166,000 | +22.9% | 2,809,912 | 0.0% | 0.71% | +111.9% | |
| AUTL | Autolus Therapeutics Limited | $238,000 | -54.7% | 39,740 | 0.0% | 0.14% | -22.0% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-05-13
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| Harpoon Therapeutics, Inc. | 15 | Q2 2023 | 27.6% |
| Repare Therapeutics, Inc. | 14 | Q3 2023 | 19.7% |
| TCR2 Therapeutics, Inc. | 14 | Q1 2023 | 18.0% |
| iTeos Therapeutics, Inc. | 13 | Q3 2023 | 15.7% |
| G1 Therapeutics, Inc. | 13 | Q4 2022 | 13.3% |
| Y Mabs Therapeutics, Inc. | 12 | Q3 2022 | 5.4% |
| Cullinan Oncology, Inc. | 11 | Q3 2023 | 41.4% |
| Epizyme, Inc. | 11 | Q2 2022 | 22.1% |
| Oncorus, Inc. | 11 | Q2 2023 | 13.3% |
| Intellia Therapeutics, Inc. | 10 | Q3 2023 | 5.5% |
View MPM BioImpact LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-15 |
| 13F-HR | 2024-02-13 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| SC 13D/A | 2023-08-01 |
| SC 13D | 2023-06-12 |
| 4 | 2023-06-05 |
| 13F-HR | 2023-05-12 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
View MPM BioImpact LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.